drugset / Trial / NCT03479320

Usefulness of Lidocaine in Oral and Maxillofacial Surgeries Under General Anesthesia for Pain Control After Operation

NCT03479320 ↗

Phase 4 Completed 40 enrolled B.P. Koirala Institute of Health Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

This will be a randomized double blinded clinical study conducted in patients undergoing oral and maxillofacial surgery under general anesthesia. Lidocaine group will receive intravenous bolus 1.5 mg/kg at induction followed by continuous infusion of 2 mg/kg/hr until the completion of surgery.Normal saline group will receive same amount of intravenous normal saline .The primary outcome will be postoperative pain using the NRS scale during first 24 hours and time to first analgesic request

Timeline

Start
2018-03-28
Primary completion
2018-12-27
Completion
2019-03-27

Outcome

Missed primary endpoint

paper does not have significant effect on reduction in postoperative pain intensity and analgesic consumption PMID 39376771 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications